Use of a solid-phase random peptide library to identify inhibitors of TNF-α mediated cytotoxicity in vitro

Cytokine

Volumn 9, Issue 4, 1997, Pages 226-232

  Chirinos Rojas, C L ^a   Steward, M W ^a   Partidos, C D ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Cytokines; Cytotoxicity; Peptide libraries; Tumour necrosis factor; Tumour necrosis factor receptor

Indexed keywords

ARGININE; CELL SURFACE RECEPTOR; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BINDING SITE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFECTION; INFLAMMATION; LIGAND BINDING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALIA;

EID: 0031128289     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0158     Document Type: Article

References (29)

1. 1. Balkwill FR, Burke F (1989) The cytokine network. Immunol Today 10:299-304.
2. 2. Tracey K, Cerami A (1993) Tumor Necrosis Factor, other cytokines and disease. Annu Rev Cell Biol 9:317-343.
3. 3. Beutler B, Cerami A (1989) The biology of Cachectin/ TNF-A human mediator on the host response. Annu Rev Immunol 7:625-655.
4. 4. Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316.
5. 5. Foxwell B, Barret K, Feldmann M (1990) Cytokine receptors: structure and signal transduction. Clin Exp Immunol 90:161-169.
6. 6. Engelmann H, Aderka A, Rubinstein M, Rotman D, Wallach D (1989) A Tumor necrosis factor-binding protein purified to homogeneity from human urine protects cell from Tumor Necrosis Factor. J Biol Chem 264:11974-11980.
7. 7. Engelman H, Novick D, Wallach D (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531-1536.
8. 8. Seckinger P, Isaaz S, Dayer JM (1989) Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem 264:11966-11973.
9. 9 Lesslauer W, Tabuchi H, Gentz R, Brockhaus M, Schlaeger E, Grau G, Piguet P, Pointaire P, Vassali P, Loetscher H (1991) Recombinant soluble Tumor Necrosis factor receptor proteins protect mice from lipolysacccaride-induced lethality. Eur J Immunol 21:2883-2886.
10. 10. Lantz M, Malik S, Slevin ML, Olsson I (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF binding protein in humans. Cytokine 2:402-406.
11. 11. Peppel K, Crawford D, Beutler B (1991) A tumor necrosis factor (TNF) receptor;-IgG heavy chain chimeric protein has bivalent antagonist of TNF activity. J Exp Med 174:1483-1489.
12. 12. Ashkenazi A, Marsters S, Capon D, Chamov S, Figari I, Pennica D, Goeddel D, Polladino M, Smith D (1992) Protection against endotoxic shock by Tumor Necrosis Factor Receptor immunoadhesin. Proc Nat Acad Sci USA 88:10535-10539.
13. 13. Haak-Frendscho M, Marsters S, Mordenti J, Brady S, Gillet N, Chen, Ashkenazi A (1994) Inhibition of TNF by a TNF Receptor Immunoadhesin. J Immunol 152:1347-1353.
14. 14. Hwang Ch, Gatanaga M, Innis E, Yamamoto R, Granger G, Gatanaga T (1991) A 20 amino acid synthetic peptide of a region from 55 kDa human tumor necrosis factor receptor inhibits cytolytic and binding activities of a recombinant human TNF in vitro. Proc R Soc Lond B 245:115-119.
15. 15. Lie B, Tunemoto D, Hemmi H, Mizukami Y, Fukuda H, Kikuchi H, Kato S, Numamo N (1992) Identification of the binding site of 55 kDa tumor necrosis factor receptor by synthetic peptides. Biochem Biophys Res Commun 188:503-509.
16. 16. Scott S, Craig L (1994) Random peptide libraries. Cell Biology 5:40-48.
17. 17. Lam K, Salmon K, Hersh E, Hruby V, Kazmierski W, Knapp R (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354:82-86.
18. 18. Devlin JJ, Panganiban LC, Devlin PE (1990) Random peptide libraries: a source of specific protein binding molecules. Science 249:404-406.
19. 19. Goodson RJ, Doyle MV, Kaufman SE, Rosenberg, S (1994) High affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci USA 91:7129-7133.
20. 20. O'Neil KT, Hoess RH, Jackson SA, Ramachandran NS, Mousa SA, DeGrado WF (1992) Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 14:509-515.
21. 21. Shaw DM, Stanley CM, Partidos CD, Steward MW (1993) Influence of the T helper epitope on the titre and affinity of antibodies to B cell epitopes after co-immunization. Mol Immunol 30, 11:961-968.
22. 22. Lifson J, Hwang K, Nara P, Fraser B, Padgett M, Dunlop N, Eiden L (1988) Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 241:712-716.
23. 23. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV (1991) Cloning and expression and cross-linking analysis of the murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834.
24. 24. Dembic Z, Loetscher H, Gubler U, Pan Y-CE, Lahm HW, Gentz R, Brockhaus M, Lesslauer W (1990) Two human TNF receptors have similar extracellular but distinct intracellular domain sequences. Cytokine 2:231-237.
25. 25. Banner DW, D'Arcy A, James W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W (1993) Crystal structure of the soluble human 55kd TNF receptor-human TNFb complex: Implications for TNF receptor activation. Cell 73:431-445.
26. 26. Butler D, Scallon B, Meager A, Kissonerghis M, Corcoran A, Chernajovsky Y, Feldmann M, Ghrayeb J, Brennan F (1994) TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells. Cytokine 6:616-623.
27. 27. Meager A (1991) A cytotoxicity assay for tumor necrosis factor using a human rhabdomiosarcoma cell line. J Immunol Methods 144:141-143.
28. 28. Steward MD, Stanley CM, Obeid OE (1995) A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response. Journal of Virology 69:7668-7673.
29. 29. Partidos CD, Obeid OE, Steward MW (1992) Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunoigenic peptides. Immunology 77:262-266.